首页 | 本学科首页   官方微博 | 高级检索  
检索        

益气活血解毒方对小鼠卵巢癌ID-8细胞株增殖及血管生成过程的影响
引用本文:李怡帆,李娟,卢雯平.益气活血解毒方对小鼠卵巢癌ID-8细胞株增殖及血管生成过程的影响[J].中国实验方剂学杂志,2018,24(4):154-159.
作者姓名:李怡帆  李娟  卢雯平
作者单位:中国中医科学院 广安门医院, 北京 100053;北京中医药大学, 北京 100029,中国中医科学院 广安门医院, 北京 100053,中国中医科学院 广安门医院, 北京 100053
基金项目:国家自然科学基金项目(81473566)
摘    要:目的:研究益气活血解毒方抑制鼠卵巢上皮癌ID-8细胞株增殖的作用,并观察本方对于脐静脉内皮细胞(HUVECs)形成血管过程的作用,为本方发挥疗效提供实验依据。方法:采用细胞增殖与检测方法(cell counting kit-8,CCK-8)检测本方对于ID-8细胞增殖的抑制作用;将含中药血清、磁珠分选的调节性T细胞(regulatory T cells,Tregs)与抗血管内皮生长因子(VEGF)抗体分组共培养,观察血管生成情况差异。结果:与空白组比较,10%,20%含药血清均能够抑制卵巢上皮癌ID-8细胞株的增殖,此抑制作用在培养96 h时最明显;在72,96 h时,20%含药血清组的抑制率明显高于10%含药血清组(P0.05,P0.01)。与Tregs(-)各组相比,Tregs(+)各组HUVECs细胞呈现明显的血管网状结构,中药含药血清组血管成网不明显,VEGF抗体联合含药血清组血管成网情况最差。结论:益气活血解毒方对小鼠卵巢上皮癌ID-8细胞株的增殖过程有显著的抑制作用,同时能够干预血管的形成,这也许与本方影响Tregs促进肿瘤新生血管的作用相关。

关 键 词:益气活血解毒方  卵巢癌  ID-8细胞株  调节T细胞  肿瘤血管
收稿时间:2017/7/11 0:00:00

Effect of Yiqi Huoxue Jiedu Decoction on Proliferation of Ovarian Cancer ID-8 Cells and Angiogenesis
LI Yi-fan,LI Juan and LU Wen-ping.Effect of Yiqi Huoxue Jiedu Decoction on Proliferation of Ovarian Cancer ID-8 Cells and Angiogenesis[J].China Journal of Experimental Traditional Medical Formulae,2018,24(4):154-159.
Authors:LI Yi-fan  LI Juan and LU Wen-ping
Institution:Guang''anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China;Beijing University of Chinese Medicine, Beijing 100029, China,Guang''anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China and Guang''anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
Abstract:Objective: To analyze the inhibitory effects of Yiqi Huoxue Jiedu decoction on proliferation of ovarian epithelial carcinoma ID-8 cells in vitro, observe the effect of this method on angiogenesis of human umbilical vein endothelial cells (HUVECs), and provide experimental basis for its efficacy. Method: Cell counting kit-8 (CCK-8) was used to testify the inhibitory effect of Yiqi Huoxue Jiedu decoction on the proliferation of ovarian cancer ID-8 cells; decoction serum, regulatory T cells (Tregs) isolated by immune magnetic MACS MicroBeads, as well as vascular endothelial growth factors (VEGF) were co-cultured, and then the angiogenesis of HUVEC was observed. Result: As compared with blank control group (fetal bovine serum group), drug serum groups with concentration of 10% and 20% showed inhibitory effects on ID-8 cells, and this effect was most significant at 96 h. Serum group with concentration of 20% showed remarkable advantages against 10% group at 72 h (P<0.01) and 96 h (P<0.05). HUVECs cultivated with Treg cells exhibited a better angiogenesis process. On the other hand, the vascular network was not obvious in drug serum group, and the inhibitory effect was most significant in anti-VEGF+Yiqi Huoxue Jiedu decoction. Conclusion: Yiqi Huoxue Jiedu decoction can restrict the multiplication of ovarian epithelial carcinoma ID-8 cells, and it could intervene the angiogenesis of HUVECs, which is probably associated with the intervention on Tregs.
Keywords:Yiqi Huoxue Jiedu decoction  ovarian cancer  ID-8  regulatory T cells  tumor angiogenesis
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号